Sunflower Pharmaceuticals Group Co Ltd
Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, adult digestive system, respiratory and cold, rheumati… Read more
Sunflower Pharmaceuticals Group Co Ltd (002737) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.028x
Based on the latest financial reports, Sunflower Pharmaceuticals Group Co Ltd (002737) has a cash flow conversion efficiency ratio of -0.028x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-117.97 Million) by net assets (CN¥4.23 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sunflower Pharmaceuticals Group Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Sunflower Pharmaceuticals Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sunflower Pharmaceuticals Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sunflower Pharmaceuticals Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gr. Sarantis S.A
PINK:SRTSF
|
-0.005x |
|
Surya Esa Perkasa Tbk
JK:ESSA
|
0.075x |
|
Chinhung International Inc. Pfd. Series 2
KO:002787
|
-0.027x |
|
SCOR PK
PINK:SCRYY
|
0.063x |
|
NORTHRIM BA. DL-01
F:NRI
|
N/A |
|
Sichuan Golden Summit Group Joint Stock Co Ltd
SHG:600678
|
0.058x |
|
Neurones
PA:NRO
|
0.032x |
|
China Education Group Holdings Limited
PINK:CEGHF
|
0.026x |
Annual Cash Flow Conversion Efficiency for Sunflower Pharmaceuticals Group Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.59 Billion | CN¥-307.48 Million | -0.067x | -136.31% |
| 2023-12-31 | CN¥5.00 Billion | CN¥923.30 Million | 0.184x | -58.45% |
| 2022-12-31 | CN¥4.44 Billion | CN¥1.97 Billion | 0.444x | +101.93% |
| 2021-12-31 | CN¥3.94 Billion | CN¥865.23 Million | 0.220x | -36.27% |
| 2020-12-31 | CN¥3.39 Billion | CN¥1.17 Billion | 0.345x | +20.58% |
| 2019-12-31 | CN¥3.43 Billion | CN¥981.33 Million | 0.286x | +13.53% |
| 2018-12-31 | CN¥3.44 Billion | CN¥866.21 Million | 0.252x | +42.60% |
| 2017-12-31 | CN¥3.16 Billion | CN¥558.77 Million | 0.177x | +45.25% |
| 2016-12-31 | CN¥2.80 Billion | CN¥341.23 Million | 0.122x | +152.41% |
| 2015-12-31 | CN¥2.61 Billion | CN¥125.84 Million | 0.048x | -72.75% |
| 2014-12-31 | CN¥2.28 Billion | CN¥403.23 Million | 0.177x | -47.60% |
| 2013-12-31 | CN¥869.02 Million | CN¥293.34 Million | 0.338x | -21.79% |
| 2012-12-31 | CN¥758.39 Million | CN¥327.31 Million | 0.432x | -8.95% |
| 2011-12-31 | CN¥543.47 Million | CN¥257.60 Million | 0.474x | -- |